STERIS plc logo
STESTERIS plc

Interest Coverage Ratio: 20.98x

Is the interest coverage ratio high or low?

The interest coverage ratio of 20.98x is 143% above its 5-year average of 8.65x, near the high end of its 5-year range (-11.50x–20.98x).

As of Friday, June 26, 2026. 22.87% above its 12-month average of 17.08x.

Interest Coverage

STE Interest Coverage Ratio

20.98x

Reported quarterly interest coverage; no daily interpolation.

+3094.77% 5Y
STE Interest Coverage Ratio

STE Average Interest Coverage Ratio Chart

STE Interest Coverage Ratio

STE Current vs Average Interest Coverage Ratio Chart

STE Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

20.98x

INTEREST COVERAGE RATIO AVG TTM

17.08x

INTEREST COVERAGE RATIO AVG 3Y

11.30x

INTEREST COVERAGE RATIO AVG 5Y

9.65x

INTEREST COVERAGE RATIO AVG 10Y

9.70x

INTEREST COVERAGE RATIO AVG 15Y

10.81x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

+22.87%

CURRENT VS 3Y AVG

+85.74%

CURRENT VS 5Y AVG

+117.34%

CURRENT VS 10Y AVG

+116.24%

CURRENT VS 15Y AVG

+94.00%

CURRENT VS 20Y AVG

N/A

STE Competitors' Interest Coverage Ratio

NAMEMARKET CAPINTEREST COVERAGE RATIOTTM3Y5Y
STERIS plc (STE)$21.00B20.98x17.08x11.30x9.65x
Labcorp Holdings Inc. (LH)vs ›$22.26B6.77x5.99x5.91x8.30x
Incyte Corporation (INCY)vs ›$22.73B553.04x298.73x269.07x276.66x
Viatris Inc. (VTRS)vs ›$19.02B-5.65x0.68x1.36x1.37x
United Therapeutics Corporation (UTHR)vs ›$23.03B77.81x54.95x40.03x35.88x
BioNTech SE (BNTX)vs ›$23.07B-45.74x444.02x1201.03x1201.03x
Quest Diagnostics Incorporated (DGX)vs ›$23.08B5.79x5.88x7.29x9.45x
Zimmer Biomet Holdings, Inc. (ZBH)vs ›$18.01B4.65x5.28x5.28x4.27x
Waters Corporation (WAT)vs ›$24.41B12.84x11.03x12.05x13.28x
West Pharmaceutical Services, Inc. (WST)vs ›$24.79B1029.00x617.01x353.82x258.97x

Financial Health Indicators

Interest Coverage

21.0x

Debt/Equity

0.29

Current Ratio

2.09

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

  • < 1.5x: EBIT is less than 1.5 times interest expense
  • 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
  • 3x - 5x: EBIT is between 3 and 5 times interest expense
  • > 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio FAQ

What is the interest coverage ratio for STERIS plc (STE)?
The interest coverage ratio for STE stock is 20.98x.
Is STERIS plc's interest coverage ratio high or low?
The interest coverage ratio of 20.98x is 143% above its 5-year average of 8.65x, near the high end of its 5-year range (-11.50x–20.98x).
What is the TTM average interest coverage ratio for STERIS plc (STE)?
The TTM average interest coverage ratio for STE stock is 17.08x.
What is the 3Y average interest coverage ratio for STERIS plc (STE)?
The 3Y average interest coverage ratio for STE stock is 11.30x.
What is the 5Y average interest coverage ratio for STERIS plc (STE)?
The 5Y average interest coverage ratio for STE stock is 9.65x.
What is the 10Y average interest coverage ratio for STERIS plc (STE)?
The 10Y average interest coverage ratio for STE stock is 9.70x.
What is the 15Y average interest coverage ratio for STERIS plc (STE)?
The 15Y average interest coverage ratio for STE stock is 10.81x.

STE Interest Coverage Ratio History

DATEINTEREST COVERAGE RATIO
2026-03-3120.98x
2025-12-3118.31x
2025-09-3017.99x
2025-06-3015.47x
2025-03-3112.63x
2024-12-3112.85x
2024-09-3011.17x
2024-06-306.10x
2024-03-316.79x
2023-12-315.81x
2023-09-305.19x
2023-06-306.11x
2023-03-317.44x
2022-12-316.26x
2022-09-30-11.50x
2022-06-306.76x
2022-03-314.22x
2021-12-318.83x
2021-09-305.06x
2021-06-300.66x
2021-03-3114.43x
2020-12-3116.52x
2020-09-3016.30x
2020-06-3012.20x
2020-03-3116.18x
2019-12-3114.51x
2019-09-3012.13x
2019-06-3010.31x
2019-03-3112.81x
2018-12-315.88x
2018-09-309.35x
2018-06-308.04x
2018-03-318.73x
2017-12-318.29x
2017-09-307.77x
2017-06-306.85x
2017-03-315.08x
2016-12-312.36x
2016-09-306.37x
2016-06-306.64x
2016-03-318.72x
2015-12-312.64x
2015-09-303.03x
2015-06-307.22x
2015-03-3114.42x
2014-12-3112.72x
2014-09-3010.80x
2014-06-309.43x
2014-03-3114.05x
2013-12-3111.96x
2013-09-3010.33x
2013-06-308.22x
2013-03-3112.66x
2012-12-3115.96x
2012-09-3018.28x
2012-06-3016.25x
2012-03-3124.83x
2011-12-3117.88x
2011-09-3015.46x
2011-06-3015.11x
2011-03-3119.50x
2010-12-3111.75x
2010-09-3018.33x
2010-06-30-20.95x
2010-03-3114.01x
2009-12-3118.06x
2009-09-3016.00x
2009-06-3013.90x
2008-12-3114.26x
2008-09-3018.65x
2008-06-3019.84x

About STERIS plc

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.

Dublin, DU
17,937 employees
Healthcare / Medical - Specialties
Sector
Healthcare
Industry
Medical - Specialties
CEO
Daniel A. Carestio